by K_Shash on Fri Mar 13, 2015 7:02 pm
Hello mrozdav,
I have become a firm believer in the "AIr Bubble Technique." The first Velcade shot I got (without any air bubble) gave me a 2-inch x 3- inch (5 cm x 7.5 cm) sunburn-like rash that itched and burned and I had to apply some over the counter steroid cream to stop the burning. After posting a question on this forum, Multibilly directed me to "Dan from Arizona's" post and I learned about this technique for the first time.
Fortunately for me, the nurse assigned to give me the next weekly shot (second Velcade shot for me) was already aware of this technique and she used the air bubble without any argument or questions, and that solved the burning rash problem completely. I still had a patch of discolored skin, but no burning or itching or any problems taking a shower.
Since then, I have had 11 more shots and a few chemo nurses seemed reluctant to learn anything new, particularly from a patient! However, at least three nurses have learned and mastered the technique well, using a 0.2 cc air bubble, and I have found a way to insist on one of them for my shot. When done right, the discolored skin around the needle mark is barely the size of a penny.
Yes, like gardengirl wrote, putting a bit of pressure on the needle mark would help keep the Velcade from oozing back through that small needle mark. However, it does seem that the small needle mark is quickly clogged by the upper tissue under the skin and I have had no rash even if a little blood came out of the needle mark. The pressure would only help and one of the nurses told me to keep the pressure on till she could apply a band aid on the needle mark. Some chemo nurses give this shot in a slow fashion and that, too, may help stop any backflow of the Velcade after first having to push the air out of the needle mark.
My oncologist and some other university myeloma experts were not even aware of these 'little things that make a cancer patient's life less miserable'. I also feel that a lot of big institutions have the 'experts' and senior oncologists often assign the treatment dosages to the residents or to the chemo pharmacist and 'rubber stamp' the off the shelf' drug regimens. I have read numerous accounts where a patient's dex or Revlimid dosage had to be readjusted, only after some serious reactions and side effects. I am glad that my oncologist did the 'right thing' and tailored the dosage for my BMI, etc. and changed the 'off the shelf' prescription from the chemo pharmacy before signing off on the pharmacy order. All of us should expect this.
K_Shash